Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
ALKemist Bio logo — Next generation cell therapies for ALK-positive cancer patie...

ALKemist Bio

Next generation cell therapies for ALK-positive cancer patients

Founded 2023 Italy Italy 3 employees Seed Total: $6.90M Health and Wellness

General Information

Company Name ALKemist Bio
Founded Year 2023
Location Italy Italy +1
Employees 3
Industries Health and Wellness
Funding Stage Seed
Social

Get notified when ALKemist Bio moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About ALKemist Bio

ALKemist Bio is a startup dedicated to developing next-generation cell therapies for ALK-positive cancer patients. The company's slogan "Next generation cell therapies for ALK-positive cancer patients" reflects its core mission. ALKemist Bio's focus lies in engineering TCR-T cells with the specific ability to target ALK antigens found on ALK-positive cancer cells, with a primary emphasis on non-small cell lung cancer patients. Founded in 2023 and headquartered in Italy, the company recently secured a significant milestone in its journey with a €6.90M Seed Round investment on 21 December 2023 from LIFTT and Claris Ventures. This influx of capital is expected to further bolster ALKemist Bio's endeavors in revolutionizing treatments for ALK-positive cancer, potentially enhancing the standard of care for affected patients.

Taxonomy: biotech, immunooncology, oncology, celltherapy, TCR, ALK, cancer, non-small cell lung cancer, immunotherapy, precision medicine

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Seed Round •••••• 2
Investor
•••• •••• 		21 Dec 2023

Latest News

View All
Ciao, Innovation! 10 promising Italian startups you should keep and eye on in 2025 — Eu-startups
Ciao, Innovation! 10 promising Italian startups you should keep and eye on in 2025
Eu-startups Nov 23, 2025

ALKemist Bio Alternatives & Competitors

ALKemist Bio vs
Xcovery Holdings, Inc.
Xcovery Holdings, Inc. United States

Our mission is simple: to employ advanced science to create leading-edge oncology therapies!

Private Equity
19 employees
Health Care, Health and Wellness
ALKemist Bio vs
Vaxon Biotech
Vaxon Biotech

Therapeutic vaccines empowering your immune system to target cancer without harming healthy cells, f...

3 employees
Biotechnology, Health Care
ALKemist Bio vs
Caedo Oncology AS
Caedo Oncology AS Norway

We create improved treatment options for cancer patients through unique immunotherapy opportunities

Series Unknown
6 employees
Biotechnology, Health Care

FAQ About ALKemist Bio

Next generation cell therapies for ALK-positive cancer patients
ALKemist Bio was founded in 2023.
ALKemist Bio is headquartered in Italy.
ALKemist Bio operates in the following industries: Health and Wellness.
ALKemist Bio has approximately 3 employees.
ALKemist Bio has completed 1 funding round, raising a total of $6.90M. The latest funding stage is Seed.
Top alternatives and competitors to ALKemist Bio include Xcovery Holdings, Inc., Vaxon Biotech, Caedo Oncology AS, IV Diagnostics, Stellanova Therapeutics. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
ALKemist Bio and Xcovery Holdings, Inc. are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors ALKemist Bio and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes